<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01479673</url>
  </required_header>
  <id_info>
    <org_study_id>4329</org_study_id>
    <nct_id>NCT01479673</nct_id>
  </id_info>
  <brief_title>TICACOS International</brief_title>
  <acronym>P2 -RMCS</acronym>
  <official_title>Tight Caloric Balance in ICU Patients: a Multicenter, Prospective, Randomized, Controlled Study.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rabin Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Baxter Healthcare Corporation</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Rabin Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to perform a prospective, randomized, controlled blinded study in
      critically patients to assess the necessity for measuring daily resting energy expenditure as
      a guide for nutritional support. Our hypothesis is that tight caloric control will reduce the
      rate of new infections.

      Study Design :Multi-center, randomized, single blinded, controlled study. Study Population:
      newly-admitted, adult mechanically ventilated ICU patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Study objectives

      To evaluate the effect of tight caloric control in critical patients on:

        -  The rate of acquired nosocomial infections (Ventilated associated pneumonia, Catheter
           related infections, Urinary tract infections)

        -  Mortality rates, length of stay in the ICU and in hospital, length of ventilation and
           incidence of non-infectious complications.

      Primary endpoint:

      Rate of nosocomial infections (for definitions see appendage 1) acquired after 48 to 72 hours
      following admission.

      Secondary endpoints

        -  Metabolic control: glucose concentration, insulin administration, rate of hypoglycemic
           events.

        -  Success of tight caloric control: accumulative and maximum negative energy balance.

        -  Organ function: SOFA score.

        -  Rate of non-infectious complications: requirement for surgery or occurrence of pressure
           sores.

        -  Length of ICU stay and of assisted ventilation (LOS and LOV)

        -  ICU survival rate.

        -  Patient status and disposition on day 28 or at hospital discharge.

        -  3 &amp; 6 months survival.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>November 2011</start_date>
  <completion_date type="Anticipated">December 2014</completion_date>
  <primary_completion_date type="Anticipated">December 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Rate of nosocomial infections</measure>
    <time_frame>After 48 to 72 hours /daily assessment: within 28 day</time_frame>
    <description>Rate of nosocomial infections acquired after 48 to 72 hours following admission up to day 28/or discharge will be evaluated</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Metabolic control</measure>
    <time_frame>Day 1 up to day 28/or discharge</time_frame>
    <description>Glucose concentration, insulin administration, rate of hypoglycemic events will be daily assessed</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Caloric control</measure>
    <time_frame>Day 1 up to day 28/or discharge</time_frame>
    <description>Success of tight caloric control:accumulative and maximum negative energy balance</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">560</enrollment>
  <condition>Mechanical Ventilation Complication</condition>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Patients in this group will receive enteral nutrition/parenteral nutrition or combination of enteral and parenteral nutrition according to the &quot;liberal &quot; regimen, i.e. according to local practice.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Indirect Calorimetry</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Study group: Indirect Calorimetry (IC) Patients in this group will receive enteral nutrition/parenteral nutrition or combination of enteral and parenteral nutrition according to the individual energy requirements calculated by Indirect Calorimetry measurement of Resting Energy Expenditure (REE).</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Indirect Calorimetry measurement of Resting Energy Expenditure .</intervention_name>
    <description>Patients in this group will receive enteral nutrition/parenteral nutrition or combination of enteral and parenteral nutrition according to the individual energy requirements calculated by Indirect Calorimetry.</description>
    <arm_group_label>Indirect Calorimetry</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Mechanically-ventilated adults(Male or Female)admitted to general ICU within the first
             48 hours of ICU admission.

          2. Age ≥ 18 years;no upper age limit.

          3. Expected stay in ICU&gt; 3 days: [SAPS II (18) &gt; ICU median or high-level of nursing care
             implemented or per clinical impression of attending physician]

          4. Medical and abdomino/thoracic surgery patients, as well as multiple trauma patients
             with Glasgow Coma Score ≥ 10.

        Exclusion Criteria:

          1. Pregnancy.

          2. DNR order.

          3. Readmission in the ICU during the same hospitalization/transfer from other ICU.

          4. Admission for postoperative monitoring.

          5. Respiratory instability: SpO2 &lt;90% or need for ventilator adjustments during the
             preceding hour or hyperventilation (Respiratory rate &gt; 35/min)

          6. Bicarbonate infusion, loss of bicarbonate (diarrhea, ureterosogmoidostomy or use of
             acetazoloamide, ultrafiltration).

          7. Aerosolization with nitric oxide or heliox, tracheal insufflations or visible leaks in
             chest drainage system.

          8. FiO2 80% or patients requiring prone position

          9. Chronic/acute liver failure:Child-Pugh class C

         10. Brain injury for various reasons with Glasgow Coma Scale below 10.

         11. Cardiac surgery patients.

         12. Patients in the hospital for more than 7 days.

         13. Contra indication to use enteral nutrition.

         14. Participation in a clinical study with an investigational drug within one month prior
             to the start of this clinical trial.

         15. Ethical issues that will influence subject eligibility.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pierre Singer, MD, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>RabinMC,Beilinson Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Milana Grinev, RN,Study Coordinator</last_name>
    <role>Study Director</role>
    <affiliation>RabinMC, Beilinson Hospital ,Petah- Tikva, Israel</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Pierre Singer, MD,Professor</last_name>
    <phone>972-3-9376521</phone>
    <email>psinger@clalit.org.il</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Milana Grinev, RN</last_name>
    <phone>972-3-9376521</phone>
    <email>milang@clalit.org.il</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Rabin Medical Center, Campus Beilinson</name>
      <address>
        <city>Petach Tikva</city>
        <zip>49100</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pierre Singer, Professor ,MD</last_name>
      <phone>972-39376521</phone>
      <email>psinger@clalit.org.il</email>
    </contact>
    <contact_backup>
      <last_name>Milana Grinev, Study Coordinator</last_name>
      <phone>972-39376590</phone>
      <email>milang@clalit.org.il</email>
    </contact_backup>
    <investigator>
      <last_name>Ilya Kagan, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ronit Anbar, RD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>November 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 22, 2011</study_first_submitted>
  <study_first_submitted_qc>November 23, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 24, 2011</study_first_posted>
  <last_update_submitted>November 21, 2013</last_update_submitted>
  <last_update_submitted_qc>November 21, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 25, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Rabin Medical Center</investigator_affiliation>
    <investigator_full_name>Pierre singer</investigator_full_name>
    <investigator_title>Professor Pierre Singer, MD</investigator_title>
  </responsible_party>
  <keyword>Enteral Nutrition</keyword>
  <keyword>Parenteral Nutrition</keyword>
  <keyword>Indirect Calorimetry</keyword>
  <keyword>Intravenous Feeding</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

